Robert S. Landsman

Array ( [id] => 6187857 [patent_doc_number] => 20110171238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'NOVEL STRA6 POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/944519 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 54670 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171238.pdf [firstpage_image] =>[orig_patent_app_number] => 12944519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055817 [patent_doc_number] => 20110112177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Human G-Protein Coupled Receptor (HETGQ23)' [patent_app_type] => utility [patent_app_number] => 12/943202 [patent_app_country] => US [patent_app_date] => 2010-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12822 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112177.pdf [firstpage_image] =>[orig_patent_app_number] => 12943202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202850 [patent_doc_number] => 20110065636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3)' [patent_app_type] => utility [patent_app_number] => 12/941034 [patent_app_country] => US [patent_app_date] => 2010-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16988 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065636.pdf [firstpage_image] =>[orig_patent_app_number] => 12941034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355045 [patent_doc_number] => 08673578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Methods of identifying antagonists of the hTAS2R46 bitter taste receptor' [patent_app_type] => utility [patent_app_number] => 13/504750 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 26729 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499408 [patent_doc_number] => 20110262426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHODS AND KITS USED IN IDENTIFYING GLIOBLASTOMA' [patent_app_type] => utility [patent_app_number] => 12/911091 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17318 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262426.pdf [firstpage_image] =>[orig_patent_app_number] => 12911091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482776 [patent_doc_number] => 20120282183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'PROGNOSTIC,. SCREENING AND TREATMENT METHODS AND AGENTS FOR TREATMENT OF METASTASIS AND INFLAMMATION USING 5T4 ONCOFOETAL GLYCOPROTEIN' [patent_app_type] => utility [patent_app_number] => 13/502893 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 25028 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370158 [patent_doc_number] => 20120219543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF GLUCOSE HOMEOSTASIS' [patent_app_type] => utility [patent_app_number] => 13/502784 [patent_app_country] => US [patent_app_date] => 2010-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22827 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024811 [patent_doc_number] => 20110053137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'METHODS OF MODULATING COLD SENSORY PERCEPTION' [patent_app_type] => utility [patent_app_number] => 12/905001 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25913 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053137.pdf [firstpage_image] =>[orig_patent_app_number] => 12905001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024858 [patent_doc_number] => 20110053184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Nucleic Acid Encoding A Haplotype of Human T2R Receptor hT2R50' [patent_app_type] => utility [patent_app_number] => 12/901011 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18963 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053184.pdf [firstpage_image] =>[orig_patent_app_number] => 12901011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8515837 [patent_doc_number] => 20120315244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products' [patent_app_type] => utility [patent_app_number] => 13/499313 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 290 [patent_figures_cnt] => 290 [patent_no_of_words] => 33265 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300983 [patent_doc_number] => 20120183541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'HAIR GROWTH METHODS USING FGFR4 EXTRACELLULAR DOMAINS' [patent_app_type] => utility [patent_app_number] => 13/496182 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21112 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8080963 [patent_doc_number] => 08147801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion' [patent_app_type] => utility [patent_app_number] => 12/881695 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6093 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/147/08147801.pdf [firstpage_image] =>[orig_patent_app_number] => 12881695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007064 [patent_doc_number] => 20110059095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN PROTEASE-ACTIVATED RECEPTOR-2' [patent_app_type] => utility [patent_app_number] => 12/877133 [patent_app_country] => US [patent_app_date] => 2010-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25137 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059095.pdf [firstpage_image] =>[orig_patent_app_number] => 12877133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945120 [patent_doc_number] => 20110105740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'SOLUBLE TNF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 12/871625 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22578 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105740.pdf [firstpage_image] =>[orig_patent_app_number] => 12871625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317277 [patent_doc_number] => 08232052 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Methods of selecting a dopaminergic neuron proliferative progenitor cells using Lrp4/Corin markers' [patent_app_type] => utility [patent_app_number] => 12/868598 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15361 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12868598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754567 [patent_doc_number] => 20120027739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'T CELL RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/850425 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10025 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027739.pdf [firstpage_image] =>[orig_patent_app_number] => 12850425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347920 [patent_doc_number] => 20120208845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'Agonists and Antagonists of Human Bitter Taste Receptor TAS2R49 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/384956 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24360 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118561 [patent_doc_number] => 20110076234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'PEPTIDES COMPRISING AN ISODGR MOTIF' [patent_app_type] => utility [patent_app_number] => 12/836480 [patent_app_country] => US [patent_app_date] => 2010-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24543 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076234.pdf [firstpage_image] =>[orig_patent_app_number] => 12836480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096134 [patent_doc_number] => 20110003317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'METHODS OF SCREENING COMPOUNDS FOR INSECT-CONTROL ACTIVITY INVOLVING THE TYRAMINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/822139 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9859 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003317.pdf [firstpage_image] =>[orig_patent_app_number] => 12822139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6609466 [patent_doc_number] => 20100323456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Endothelin Receptors in Morphine Withdrawal' [patent_app_type] => utility [patent_app_number] => 12/821994 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3612 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323456.pdf [firstpage_image] =>[orig_patent_app_number] => 12821994 [rel_patent_id] =>[rel_patent_doc_number] =>)